CD68-and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and systematic review

被引：0
|
作者：
Chao, N. [1 ]
Xia, W. [1 ]
Yu, K. [1 ]
Yuan, H. [1 ]
Zhang, W. [1 ]
机构：
[1] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2637
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [41] Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment
    Kinoshita, Jun
    Fushida, Sachio
    Yamaguchi, Takahisa
    Moriyama, Hideki
    Saito, Hiroto
    Shimada, Mari
    Terai, Shiro
    Okamoto, Koichi
    Nakamura, Keishi
    Ninomiya, Itasu
    Yagi, Shintaro
    Inaki, Noriyuki
    BMC CANCER, 2022, 22 (01)
  • [42] Effect of markers of systemic inflammation on tumor infiltrating lymphocytes in patients with non-metastatic triple negative and HER2+breast cancer: A single center retrospective study
    Chen, Nan
    Bulsara, Shaun
    Hilsenbeck, Susan
    Hoyos, Valentina
    CANCER RESEARCH, 2022, 82 (04)
  • [43] Prognostic significance of intraepithelial CD103-positive tumor-infiltrating lymphocytes in breast cancer
    Bae, Young Kyung
    Park, Min Hui
    Choi, Jung Eun
    Kang, Su Hwan
    Gong, Gyungyub
    CANCER RESEARCH, 2020, 80 (04)
  • [44] Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer
    Raphael, Jacques
    Gong, I. Y.
    Nofech-Mozes, S.
    Bartlett, J. M. S.
    Nafisi, H.
    Verma, S.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (06) : 552 - 555
  • [45] Retrospective study about the prevalence of (TILs) tumour infiltrating lymphocytes in non-metastatic triple negative breast cancer patients and its prognostic value
    Kamal, A. M.
    Elghazaly, H. A.
    El-Mahdy, M. M.
    Adel, A. M.
    Abdel-Kader, N. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S40 - S41
  • [46] The immune micro-environment of inflammatory breast cancer is characterized by an influx of CD163+tumor-associated macrophages
    Van Berckelaer, Christophe
    Van Laere, Steven
    Colpaert, Cecile
    Bertucci, Francois
    Kockx, Mark
    Dirix, Luc Yves
    Van Dam, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Intratumoral CD68-, CD117-, CD56-, and CD1a-positive immune cells and the survival of Iranian patients with non-metastatic intestinal-type gastric carcinoma
    Amoueian, Sakineh
    Attaranzadeh, Armin
    Montazer, Mehdi
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (04) : 326 - 331
  • [48] Xiap expression is associated with infiltration of cd163+tumor-associated macrophages in the tumor micro-environment of inflammatory breast cancer
    Van Berckelaer, Christophe
    Van Laere, Steven
    Gerardts, Joseph
    Dirix, Luc
    Morse, Michael
    Kockx, Mark
    Bertucci, Francois
    Van Dam, Peter
    Devi, Gayathri R.
    CANCER RESEARCH, 2022, 82 (04)
  • [49] Tumor-associated macrophages: CD206 and CD68 expression and patient outcomes in locally advanced breast cancer.
    Williams, Chelsea Nicole
    Hodges, David Blake
    Reynolds, Jana Marie
    Bhat, Ashwini
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] THE RELATIONSHIP OF TUMOUR-ASSOCIATED MACROPHAGES (CD68, CD163, CD 1 1C) AND CANCER STEM CELL (CD44) MARKERS WITH PROGNOSTIC PARAMETERS IN BREAST CARCINOMAS
    Sari, Suna
    Ozdemir, Cigdem
    Cilekar, Murat
    POLISH JOURNAL OF PATHOLOGY, 2022, 73 (04) : 303 - 309
12345